Page 85 - SAMRC Annual Report 2023-24
P. 85

PERFORMANCE INFORMATION









                                                               Malaria Research Group






                                                               Platform director:
                                                               Prof. Rajendra Maharaj








            Prioritising responsive research                      funded the scale-up of IRS to reduce disease
            through impactful interventions                       burden. Funds were also used to measure the
                                                                  impact of IRS on disease transmission. The
            The Malaria Research Group (MRG) is committed to      study revealed IRS provided good coverage of
            (1) Ensuring all South Africans have access to quality,   targeted houses and subsequently protected
            safe, effective, affordable malaria interventions     resident populations.
            through timely and sustainable initiatives that
            reinforce the elimination agenda, (2) To generate   (iii)  Determining  the  efficacy  of  Transfluthrin  on
            new knowledge and tools to further the malaria        Anopheles Arabiensis over 28 Days using sticker
            elimination agenda, and (3). To provide a platform    envelope that releases the active ingredient. This
            for malaria scientists in-country and sub-regionally   trial investigated Transfluthrin as an alternative to
            to share research that contributes to NdoH's          current tools used in malaria control programmes.
            elimination agenda.                                   Results revealed that the product was effective
                                                                  under laboratory conditions.
            Our  projects  over  the  2023/24  reporting  period,
            include:                                           (iv)  Laboratory  trial  to  determine  the  efficacy  of  a
                                                                  new IRS Insecticide:SYN54707 WP. The aim of the
            (i)   Lubombo Spatial Development Initiative 2 –      trial was to determine the effectiveness of a new
               Indoor residual spraying (IRS) is the main tool    insecticide on different surfaces. Results showed
               employed in South  Africa to control vectors       the insecticide was effective on four different
               and reduce malaria transmission. For successful    surface types over 12 months.
               control it is vital to determine the resistance
               profile  of  vectors.  The  project  aimed  to
               determine  the  insecticide  resistance  profile  of
               vectors in three endemic provinces of Limpopo,
               Mpumalanga and KwaZulu-Natal. Laboratory
               tests  revealed  field-collected  mosquitoes  were
               vulnerable  to  insecticides  used  by  provincial
               control  programmes.  This  influences  vector
               control policy.
            (ii)   Source reduction of malaria incidence in southern
               Mozambique. Monitoring and evaluation of the
               indoor residual spraying (IRS) programme in
               selected districts in southern Mozambique. MRG
               was awarded a R14 million tender by NDoH to       MRG Insectary: Advancing Lab Trials for
               monitor and evaluate the quality and impact of    Malaria Research.
               IRS in three districts in Mozambique. The grant




                                                              SAMRC  ANNUAL REPOR T 2023-24               83
   80   81   82   83   84   85   86   87   88   89   90